| Product ID |
Product Name |
CAS# |
Purity |
| Y1237210 |
KX-01-191 |
2211903-84-1 |
99% |
| Y1246030 |
RIPK1-IN-7 |
2300982-44-7 |
98% |
| Y1237139 |
Foliglurax monohydrochloride |
2133294-96-7 |
98% |
| Y1237114 |
KPLH1130 |
906669-07-6 |
99% |
| Y1241576 |
BNC375 |
1557240-80-8 |
99% |
| Y1241691 |
Valemetostat tosylate |
1809336-93-3 |
98% |
| Y1241645 |
c-Fms-IN-1 |
885703-64-0 |
99% |
| Y3104551 |
N-Boc-N-cyclobutyl-glycine |
1779868-81-3 |
97% |
| Y3312946 |
N6-[(2-Azidoacetyl)glycyl]-L-lysine HCl |
2407768-11-8 |
97% |
| Y3314526 |
Ailanthoidol |
156398-61-7 |
97.5% |
| Y3104552 |
N-Fmoc-N-(3-buten-1-yl)-glycine |
227006-55-5 |
98% |
| Y3314595 |
Dehydrovomifoliol |
39763-33-2 |
96.5% |
| Y3316691 |
(4R)-1-Fmoc-4-isobutoxy-L-proline |
865353-14-6 |
97% |
| Y3294664 |
BT18 |
924811-53-0 |
99% |
| Y1237206 |
mAChR-IN-1 hydrochloride |
119391-73-0 |
99% |
| Y1246032 |
UCSF924 |
1434515-70-4 |
99% |
| Y3316221 |
Ursolic aldehyde |
19132-81-1 |
95% |
| Y1237140 |
XP-59 |
890402-73-0 |
98% |
| Y1313137 |
Actyflon-G05 |
20109-57-3 |
96% |
| Y3295036 |
N-Boc-3-chloro-D-alanine |
87156-12-5 |
97% |
| Y3290288 |
N-Fmoc-N-(3-buten-1-yl)-L-phenylalanine |
1188391-93-6 |
97% |
| Y3316063 |
N-Boc-S-2-Pyridinylthio-L-cysteine |
117310-07-3 |
97% |
| Y3106296 |
N-Fmoc-O-propyl-L-serine |
2255321-09-4 |
98% |
| Y1241577 |
L-745870 hydrochloride |
1173023-36-3 |
99% |
| Y3313030 |
N-Fmoc-N,1-dimethyl-L-tryptophan |
2413047-17-1 |
97% |
| Y1237207 |
Tipepidine hydrochloride |
1449686-84-3 |
99% |
| Y1342516 |
1-Cbz-4-amino-4-piperidineacetic acid |
303037-50-5 |
97% |
| Y1241561 |
MAC glucuronide phenol-linked SN-38 |
2246380-69-6 |
96% |
| Y3313196 |
N-Fmoc-4-methyl-3-chloro-L-phenylalanine |
1998646-41-5 |
97%,ee98% |
| Y3306954 |
DPDPE TFA |
172888-59-4 |
99% |
| Y3260817 |
LY377604 |
204592-94-9 |
99% |
| Y1250214 |
VU0650786 |
1809085-30-0 |
99% |
| Y3106346 |
Dehydroperilloxin |
263241-09-4 |
95% |
| Y3306491 |
Endomorphin 2 TFA |
1276124-00-5 |
98% |
| Y3260531 |
FAAH-IN-1 |
1242441-47-9 |
99% |
| Y3106331 |
Desoxo-narchinol A |
53859-06-6 |
98.0% |
| Y3291432 |
PS10 |
1564265-82-2 |
99% |
| Y3305401 |
Leuphasyl TFA |
67586-27-0 |
98% |
| Y3305980 |
[Leu5]-Enkephalin TFA(58822-25-6(free bas)) |
73563-78-7 |
99% |
| Y3294702 |
MELK-IN-1 |
2095596-44-2 |
98% |
| Y3313466 |
Senkyunolide E |
94530-83-3 |
97.0% |
| Y3265114 |
CHMFL-PI3KD-317 |
2244992-76-3 |
98% |
| Y3253060 |
PROTAC EED degrader-1 |
2639882-72-5 |
99% |
| Y3106279 |
C25-140 |
1358099-18-9 |
98% |
| Y1241452 |
FT-1518 |
1313026-58-2 |
98% |
| Y3269666 |
PDK1-IN-RS2 |
1643958-89-7 |
98% |
| Y3295858 |
S130 |
1160852-22-1 |
99% |
| Y3288312 |
ZL0580 |
2377151-10-3 |
99% |
| Y3289001 |
GS-9901 |
1640247-87-5 |
99% |
| Y3106293 |
Neotripterifordin |
149249-32-1 |
98.5% |
| Y3295895 |
Selective PI3Kd Inhibitor 1 |
2088525-31-7 |
99% |
| Y3310630 |
ZEN-3411 |
1952264-36-6 |
97% |
| Y1245789 |
AZD3458 |
2132961-46-5 |
99% |
| Y3310351 |
MMP3 inhibitor 1 |
312930-75-9 |
99% |
| Y3306147 |
CGS 27023A |
161314-82-5 |
95% |
| Y3255727 |
EGFR-IN-8 |
2407957-87-1 |
98% |
| Y3306278 |
EGFR-IN-1 hydrochloride |
2227455-78-7 |
99% |
| Y3310550 |
GSK-3ß inhibitor 1 |
187325-53-7 |
99% |
| Y1241478 |
AS1810722 |
909561-15-5 |
98% |
| Y3309212 |
CHMFL-ABL-039 |
2304344-56-5 |
98% |
| Y1241479 |
SB-633825 |
956613-01-7 |
98% |
| Y1241430 |
Wnt pathway activator 1 |
1360540-81-3 |
98% |
| Y3224332 |
c-Fms-IN-8 |
1255303-58-2 |
99% |
| Y3232079 |
RTC-5 |
1423077-49-9 |
99% |
| Y3228212 |
XL177A |
2417089-74-6 |
98% |
| Y1245865 |
PDGFRa kinase inhibitor 1 |
2209053-93-8 |
99% |
| Y3305293 |
Poziotinib hydrochloride |
1429757-68-5 |
97% |
| Y1342467 |
FAK inhibitor 2 |
2354405-14-2 |
98% |
| Y1342816 |
Keap1–Nrf2-IN-1 |
2232112-72-8 |
98% |
| Y1241431 |
TrkA-IN-1 |
1680179-43-4 |
98% |
| Y1250240 |
USP7-IN-3 |
2202738-42-7 |
99% |
| Y1245791 |
HS-27 |
1562024-11-6 |
98% |
| Y3184638 |
Vc-seco-DUBA |
1345681-58-4 |
99% |
| Y1241432 |
TransparentOrange3g |
61969-47-9 |
98% |
| Y3286992 |
MC-Val-Cit-PAB-rifabutin |
2055900-34-8 |
95% |
| Y3215877 |
MC-Val-Cit-PAB-Retapamulin |
1639793-15-9 |
99% |
| Y1341518 |
PPC-NB |
1887040-81-4 |
98% |
| Y3257401 |
Mal-PEG4-Val-Cit-PAB |
1949793-41-2 |
98% |
| Y3264451 |
NAMPT inhibitor-linker 2 |
2241014-82-2 |
98% |
| Y3294057 |
UAA crosslinker 1 hydrochloride |
1994331-17-7 |
98% |
| Y3177686 |
E3 ligase Ligand 18 |
2241669-88-3 |
99% |
| Y3306340 |
(S,R,S)-AHPC-C10-NH2 |
2341796-74-3 |
95% |
| Y3175065 |
DBCO-PEG4-VC-PAB-DMEA-PNU-159682 |
2259318-56-2 |
84% |
| Y1245792 |
Azido-PEG24-NHS ester |
2375600-46-5 |
95% |
| Y3254137 |
Mal-PEG4-VC-PAB-DMEA-PNU-159682 |
2259318-52-8 |
95% |
| Y1250220 |
Pomalidomide-PEG1-azide |
2133360-04-8 |
97% |
| Y3287758 |
SC-VC-PAB-DM1 |
2259318-47-1 |
93% |
| Y1254622 |
PEG3-C4-OBn |
2381196-79-6 |
98% |
| Y3262882 |
Hydroxy-PEG2-CH2COONa |
42588-76-1 |
95% |
| Y3315259 |
Menisporphine |
83287-02-9 |
95% |
| Y3295286 |
(S,R,S)-AHPC-O-Ph-PEG1-NH2 |
2361117-24-8 |
98% |
| Y3263479 |
Ipatasertib-NH2 |
1001382-14-4 |
98% |
| Y1340274 |
(S,R,S)-AHPC-Me-C5-COOH |
2229976-21-8 |
98% |
| Y3260993 |
TD-106 |
2250288-69-6 |
99% |
| Y3106340 |
K-Ras ligand-Linker Conjugate 5 |
2378261-85-7 |
98% |
| Y3269785 |
Dasatinib carbaldehyde |
2112837-79-1 |
98% |
| Y3311540 |
Hydroxy-PEG10-acid |
2375611-66-6 |
95% |
| Y1245866 |
PROTAC IRAK4 ligand-1 |
2357108-39-3 |
99% |
| Y3292434 |
Pomalidomide-amido-PEG3-C2-NH2 |
2328070-52-4 |
99% |
| Y1245867 |
PROTAC BET-binding moiety 1 |
2093387-77-8 |
80% |